Medesis Pharma Successfully Completes Phase I Clinical Trial of NP03 Baillargues, January 5, Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trial - Lithium pharmacology - Document - PDFSEARCH.IO

First Page	Meta Content
	Medesis Pharma Successfully Completes Phase I Clinical Trial of NP03 Baillargues, January 5, Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trial Add to Reading List Document Date: 2011-07-25 18:53:24 Open Document File Size: 68,26 KB Share Result on Facebook Company Medesis Pharma / Medesis Pharma Medesis Pharma / / Event FDA Phase / / / IndustryTerm drug delivery technology / pharmaceutical / stage pharmaceutical company specialising / treatment for Huntington’s disease / / MedicalCondition Huntington’s Disease Huntington's disease / dementia / disease / neurodegenerative genetic disorder / neurodegenerative diseases / Huntington’s disease / chorea / / Person Jean-Claude Maurel / Peter Jackson / / / Position President and CEO / / Product lithium citrate / NP03 / / Technology drug delivery technology / / URL www.medesispharma.com / / SocialTag Lithium pharmacology Pharmaceutical drug Lithium Pharmaceutical industry Clinical trial Pharmacology Pharmaceutical sciences Chemistry

Medesis Pharma Successfully Completes Phase I Clinical Trial of NP03 Baillargues, January 5, Medesis Pharma, the French based pharmaceutical company, announces the successful completion of a phase I clinical trialAdd to Reading List